190 related articles for article (PubMed ID: 8493750)
1. Renal-sparing surgery for renal cell carcinoma.
Novick AC
Urol Clin North Am; 1993 May; 20(2):277-82. PubMed ID: 8493750
[TBL] [Abstract][Full Text] [Related]
2. Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease.
Joly D; Méjean A; Corréas JM; Timsit MO; Verkarre V; Deveaux S; Landais P; Grünfeld JP; Richard S
J Urol; 2011 Jun; 185(6):2056-60. PubMed ID: 21496837
[TBL] [Abstract][Full Text] [Related]
3. The role of renal-sparing surgery for renal cell carcinoma.
Novick AC
Semin Urol; 1992 Feb; 10(1):12-5. PubMed ID: 1565898
[TBL] [Abstract][Full Text] [Related]
4. Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: a single center experience.
Roupret M; Hopirtean V; Mejean A; Thiounn N; Dufour B; Chretien Y; Chauveau D; Richard S
J Urol; 2003 Nov; 170(5):1752-5. PubMed ID: 14532769
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.
Park SY; Park BK; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
Acta Radiol; 2011 Jul; 52(6):680-5. PubMed ID: 21525107
[TBL] [Abstract][Full Text] [Related]
6. [Recent advances in nephron-sparing surgery for renal cell carcinoma].
Igarashi T; Tobe T; Ito H
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1726-31. PubMed ID: 12402421
[TBL] [Abstract][Full Text] [Related]
7. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
[TBL] [Abstract][Full Text] [Related]
8. Nephron-sparing surgery.
Lane BR; Novick AC
BJU Int; 2007 May; 99(5 Pt B):1245-50. PubMed ID: 17441918
[No Abstract] [Full Text] [Related]
9. [Testicular metastasis and local recurrence of renal cell carcinoma after nephron-sparing surgery in von Hippel-Lindau disease].
Nemoto K; Shimizu H; Kimura G
Hinyokika Kiyo; 2007 Mar; 53(3):163-5. PubMed ID: 17447484
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease.
Ploussard G; Droupy S; Ferlicot S; Ples R; Rocher L; Richard S; Benoit G
Urology; 2007 Sep; 70(3):435-9. PubMed ID: 17905091
[TBL] [Abstract][Full Text] [Related]
11. Conservative renal surgery. Has it a role in renal cell carcinoma?
Keane TE; Graham SD
Surg Oncol Clin N Am; 1995 Apr; 4(2):295-306. PubMed ID: 7796288
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
[TBL] [Abstract][Full Text] [Related]
13. [Two-stage nephron-sparing surgery for bilateral T2 renal cell carcinoma and von Hippel-Lindau disease: a case report].
Iguchi R; Kanematsu A; Nakamura E; Shimizu T; Watanabe J; Soda T; Kamba T; Yoshimura K; Nishiyama H; Kamoto T; Ogawa O
Hinyokika Kiyo; 2009 Aug; 55(8):483-5. PubMed ID: 19764533
[TBL] [Abstract][Full Text] [Related]
14. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
Eggener S
Eur Urol; 2010 Mar; 57(3):472. PubMed ID: 19359087
[No Abstract] [Full Text] [Related]
16. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
Russo P
Eur Urol; 2010 Mar; 57(3):472-3. PubMed ID: 19359086
[No Abstract] [Full Text] [Related]
17. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
[TBL] [Abstract][Full Text] [Related]
18. Choice of operation for clinically localized renal tumor.
Nguyen CT; Campbell SC; Novick AC
Urol Clin North Am; 2008 Nov; 35(4):645-55; vii. PubMed ID: 18992618
[TBL] [Abstract][Full Text] [Related]
19. [Enucleation of renal cell carcinoma in von Hippel-Lindau disease using a microwave tissue coagulator].
Igarashi T; Sakuma T; Yagasaki H; Igarashi T; Sugimoto S; Hirakata H; Kawata N; Takimoto Y
Hinyokika Kiyo; 2004 Feb; 50(2):91-3. PubMed ID: 15101163
[TBL] [Abstract][Full Text] [Related]
20. Nephron sparing surgery for renal tumors: indications, techniques and outcomes.
Uzzo RG; Novick AC
J Urol; 2001 Jul; 166(1):6-18. PubMed ID: 11435813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
